Effects of RIα overexpression on cisplatin sensitivity in human ovarian carcinoma cells

Biochemical and Biophysical Research Communications

Volumn 249, Issue 3, 1998, Pages 723-727

  Cvijic, Mary Ellen ^a   Chin, Khew Voon ^a  

^a RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC METAL COMPLEX; CISPLATIN; COMPLEMENTARY DNA; ANTINEOPLASTIC AGENT; CYCLIC AMP DEPENDENT PROTEIN KINASE; REGULATORY SUBUNIT RIALPHA, CYCLIC AMP DEPENDENT PROTEIN KINASE; REGULATORY SUBUNIT RIALPHA, CYCLIC-AMP-DEPENDENT PROTEIN KINASE;

ARTICLE; CARCINOMA CELL; DRUG SENSITIVITY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RETROVIRUS; ANIMAL; CELL CULTURE; CHEMISTRY; CHO CELL; DNA DAMAGE; DNA REPAIR; DRUG RESISTANCE; ENZYMOLOGY; FEMALE; GENE EXPRESSION; GENETICS; HAMSTER; METABOLISM; MOUSE; MUTATION; OVARY TUMOR; PHYSIOLOGY; PROTEIN CONFORMATION;

CRICETINAE; CRICETULUS GRISEUS; UNIDENTIFIED RETROVIRUS;

ANIMALS; ANTINEOPLASTIC AGENTS; CHO CELLS; CISPLATIN; CRICETINAE; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DNA DAMAGE; DNA REPAIR; DRUG RESISTANCE; FEMALE; GENE EXPRESSION; HUMANS; MICE; MUTATION; OVARIAN NEOPLASMS; PROTEIN CONFORMATION; TUMOR CELLS, CULTURED;

EID: 0032575384     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.1998.9223     Document Type: Article

References (23)

1. Dell'Acqua M. L., Scott J. D. J. Biol. Chem. 272:1997;12881-12884.
2. Gergley P., Bot G. FEBS Lett. 82:1977;269-272.
3. Pawson T., Scott J. D. Science. 278:1997;2075-2080.
4. Tortora G., Damiano V., Bianco C., Baldassarre G., Bianco A. R., Lanfrancone L., Pelicci P. G., Ciardiello F. Oncogene. 14:1997;923-928.
5. Tournier S., Raynaud F., Gerbaud P., Lohmann S. M., Doree M., Evain-Brion D. J. Biol. Chem. 266:1991;19018-19022.
6. Wu J. C., Wang J. H. J. Biol. Chem. 264:1989;9989-9993.
7. Khatra B. S., Printz R., Cobb C. E., Corbin J. D. Biochem. Biophys. Res. Commun. 130:1985;567-572.
8. Tortora G., Pepe S., Bianco C., Baldassarre G., Budillon A., Clair T., Cho-Chung Y. S., Bianco A. R., Ciardiello F. Oncogene. 9:1994;3233-3240.
9. Tortora G., Pepe S., Bianco C., Damiano V., Ruggiero A., Baldassarre G., Corbo C., Cho-Chung Y. S., Bianco A. R., Ciardiello F. Int. J. Cancer. 59:1994;712-716.
10. North P. S., Davies S. L., Ciardiello F., Damiano V., Bianco C., Pepe S., Bianco A. R., Harris A. L., Hickson I. D., Tortora G. Cancer Res. 54:1994;4123-4128.
11. Liu B., Cvijic M. E., Jetzt A., Chin K.-V. Cell Growth Differ. 7:1996;1105-1112.
12. Cvijic M. E., Chin K.-V. Int. J. Cancer. 72:1997;345-350.
13. Cvijic M. E., Yang W.-L., Chin K.-V. Pharmacol. Therap. 78:1998;115-128.
14. Wigler M., Sweet R., Sim G. K., Wold B., Pellicer A., Lacy E., Maniatis T., Silverstein S., Axel R. Cell. 16:1979;777-786.
15. Mossman T. J. Immunol. Methods. 65:1983;55-63.
16. Mann S. C., Andrews P. A., Howell S. B. Int. J. Cancer. 48:1991;866-872.
17. Petru E., Boike G., Sevin B. U. J. Cancer Res Clin. Oncol. 116:1990;431-433.
18. Howell S. B., Vick J., Andrews P. A., Velury S., Sanga S. Proceedings of the Fifth International Symposium on Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy. 1987;Martinus Nijoff, Padua. p. 228-234.
19. Roberts J. J., Kotsaki-Kovatsi V. P. Mutat. Res. 165:1986;207-220.
20. Tomita K., Tsuchiya H. Clin. Therapeutics. 11:1989;43-52.
21. Keane T. E., Rosner G., Donaldson J., Norwood D. L., Poulton S. H., Walther P. J. J. Urol. 144:1990;1004-1009.
22. Takagi K., Satake T., Hasegawa T., Miyamoto K., Wakusawa S., Matsunaga T., Koshiura R. Jpn. J. Pharmacol. 45:1987;69-77.
23. Alaoui-Jamali M., Loubaba B. B., Robyn S., Tapiero H., Batist G. Cancer Chemother. Pharmacol. 34:1994;153-158.